• 1
    Besedovsky HO, del Rey A 1996 Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 17:64102.
  • 2
    Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL 1989 Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 86:23742378.
  • 3
    Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS 1992 Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 35:12811288.
  • 4
    Horowitz MC, Lorenzo JA 1996 Local regulators of bone: IL-1, TNF, lymphotoxin, interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 family, and additional cytokines. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, pp. 687700.
  • 5
    Canalis E 1996 Clinical review 83: Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:34413447.
  • 6
    Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:13511362.
  • 7
    Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC, Whorwood CB 1996 Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet 347:8891.
  • 8
    Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ 1997 11β-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94:1492414929.
  • 9
    Bujalska IJ, Kumar S, Stewart PM 1997 Does central obesity reflect “Cushing's disease of the omentum”? Lancet 349:12101213.
  • 10
    Stewart PM 1996 11β-Hydroxysteroid dehydrogenase: Implications for clinical medicine. Clin Endocrinol (Oxf) 44:493499.
  • 11
    Tannin GM, Agarwal AK, Monder C, New MI, White PC 1991 The human gene for 11β-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem 266:1665316658.
  • 12
    Stewart PM, Murry BA, Mason JI 1994 Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab 79:480484.
  • 13
    Cooper MS, Walker EA, Bland R, Fraser W, Hewison M, Stewart PM 2000 Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone. Bone 27:375381.
  • 14
    Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie AJ, Stewart PM 1998 Expression of type 2 11β-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life. J Clin Endocrinol Metab 83:44904497.
  • 15
    Bland R, Worker CA, Noble BS, Eyre LJ, Bujalska IJ, Sheppard MC, Stewart PM, Hewison M 1999 Characterization of 11β-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. J Endocrinol 161:455464.
  • 16
    Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D 1999 Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 96:25142519.
  • 17
    Robey PG, Termine JD 1985 Human bone cells in vitro. Calcif Tissue Int 37:453460.
  • 18
    Bujalska I, Shimojo M, Howie A, Stewart PM 1997 Human 11β-hydroxysteroid dehydrogenase: Studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue. Steroids 62:7782.
  • 19
    Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248254.
  • 20
    Eyre LJ, Bland R, Bujalska IJ, Sheppard MC, Stewart PM, Hewison M 1998 Characterization of aromatase and 17β-hydroxysteroid dehydrogenase expression in rat osteoblastic cells. J Bone Miner Res 13:9961004.
  • 21
    Whorwood CB, Mason JI, Ricketts ML, Howie AJ, Stewart PM 1995 Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol Cell Endocrinol 110:R7R12.
  • 22
    Stewart PM, Krozowski ZS 1999 11β-Hydroxysteroid dehydrogenase. Vitam Horm 57:249324.
  • 23
    Rajan V, Edwards CR, Seckl JR 1996 11β-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 16:6570.
  • 24
    Escher G, Galli I, Vishwanath BS, Frey BM, Frey FJ 1997 Tumor necrosis factor alpha and interleukin 1β enhance the cortisone/cortisol shuttle. J Exp Med 186:189198.
  • 25
    Tetsuka M, Haines LC, Milne M, Simpson GE, Hillier SG 1999 Regulation of 11β-hydroxysteroid dehydrogenase type 1 gene expression by LH and interleukin-1β in cultured rat granulosa cells. J Endocrinol 163:417423.
  • 26
    Tetsuka M, Milne M, Simpson GE, Hillier SG 1999 Expression of 11β-hydroxysteroid dehydrogenase, glucocorticoid receptor, and mineralocorticoid receptor genes in rat ovary. Biol Reprod 60:330335.
  • 27
    Evagelatou M, Peterson SL, Cooke BA 1997 Leukocytes modulate 11β-hydroxysteroid dehydrogenase (11β-HSD) activity in human granulosa-lutein cell cultures. Mol Cell Endocrinol 133:8188.
  • 28
    Costas M, Trapp T, Pereda MP, Sauer J, Rupprecht R, Nahmod VE, Reul JM, Holsboer F, Arzt E 1996 Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-α priming increases glucocorticoid inhibition of TNF-α-induced cytotoxicity/apoptosis. J Clin Invest 98:14091416.
  • 29
    Sun K, Yang K, Challis JR 1997 Differential regulation of 11β-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation. Endocrinology 138:49124920.
  • 30
    Mbalaviele G, Meng A, Naika H, van den Bos C, Hu G, Firestone GL, Thiede M 1999 Cloning of serum and glucocorticoid-regulated kinase using a co-culture system of human mesenchymal stem cells and hematopoietic stem cells. J Bone Miner Res 14:S151. (abstract)
  • 31
    Farahat MN, Yanni G, Poston R, Panayi GS 1993 Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 52:870875.
  • 32
    Gough AK, Lilley J, Eyre S, Holder RL, Emery P 1994 Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:2327.
  • 33
    Peel NF, Spittlehouse AJ, Bax DE, Eastell R 1994 Bone mineral density of the hand in rheumatoid arthritis. Arthritis Rheum 37:983991.
  • 34
    Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, Nuki G, Pavelka K, Rau R, Rozman B, Watt I, Williams B, Aitchison R, McCabe D, Musikic P 1998 Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41:21962204.
  • 35
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ 1999 A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253259.